Pharmasyntez-Nord

Pharmasyntez-Nord is a major Russian pharmaceutical company based in St. Petersburg, specializing in the development and large-scale production of modern cytostatic anti-cancer drugs and biotechnological products. As a key subsidiary of the Pharmasyntez Group, the company operates advanced manufacturing facilities within the St. Petersburg Special Economic Zone, focusing on import substitution for critical medications. Its portfolio includes a wide range of oncology therapeutics, insulin analogs, and biosimilar monoclonal antibodies. Pharmasyntez-Nord gained significant international attention for its role in manufacturing the Sputnik V COVID-19 vaccine and continues to expand its capacity for complex biologics and innovative drug delivery systems.